FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2889201576> ?p ?o ?g. }

• W2889201576 endingPage "91" @default.
• W2889201576 startingPage "84" @default.
• W2889201576 abstract "The National Comprehensive Cancer Network (NCCN) has recently endorsed the stratification of intermediate-risk prostate cancer (IR-PCa) into favorable and unfavorable subgroups and recommend the addition of androgen deprivation therapy (ADT) to radiation therapy (RT) for unfavorable IR-PCa. Recently, more accurate prognostication was demonstrated by integrating a 22-feature genomic classifier (GC) to the NCCN stratification system. Here, we test the utility of the GC to better identify patients with IR-PCa who are sufficiently treated by RT alone.We identified a novel cohort comprising 121 patients with IR-PCa treated with dose-escalated image guided RT (78 Gy in 39 fractions) without ADT. GC scores were derived from tumors sampled in diagnostic biopsies. Multivariable analyses, including both NCCN subclassification and GC scores, were performed for biochemical failure (prostate-specific antigen nadir + 2 ng/mL) and metastasis occurrence.By NCCN subclassification, 33 (27.3%) and 87 (71.9%) of men were classified as having favorable and unfavorable IR-PCa, respectively (1 case unclassifiable). GC scores were high in 3 favorable IR-PCa and low in 60 unfavorable IR-PCa. Higher GC scores, but not NCCN risk subgroups, were associated with biochemical relapse (hazard ratio, 1.36; 95% confidence interval [CI], 1.09-1.71] per 10% increase; P = .007) and metastasis (hazard ratio, 2.05; 95% CI, 1.24-4.24; P = .004). GC predicted biochemical failure at 5 years (area under the curve, 0.78; 95% CI, 0.59-0.91), and the combinatorial NCCN + GC model significantly outperformed the NCCN alone model for predicting early-onset metastasis (area under the curve for 5-year metastasis of 0.89 vs 0.86 [GC alone] vs 0.54 [NCCN alone]).We demonstrated the accuracy of the GC for predicting disease recurrence in IR-PCa treated with dose-escalated image guided RT alone. Our findings highlight the need to evaluate this GC in a prospective clinical trial investigating the role of ADT-RT in clinicogenomic-defined IR-PCa subgroups." @default.
• W2889201576 created "2018-09-07" @default.
• W2889201576 creator A5006261789 @default.
• W2889201576 creator A5007657275 @default.
• W2889201576 creator A5009885568 @default.
• W2889201576 creator A5014582211 @default.
• W2889201576 creator A5017800332 @default.
• W2889201576 creator A5020744487 @default.
• W2889201576 creator A5031467567 @default.
• W2889201576 creator A5050503254 @default.
• W2889201576 creator A5053710126 @default.
• W2889201576 creator A5059043243 @default.
• W2889201576 creator A5063690225 @default.
• W2889201576 creator A5069008365 @default.
• W2889201576 creator A5078925966 @default.
• W2889201576 creator A5081861396 @default.
• W2889201576 creator A5082084084 @default.
• W2889201576 creator A5086730784 @default.
• W2889201576 date "2019-01-01" @default.
• W2889201576 modified "2023-10-12" @default.
• W2889201576 title "Genomic Classifier for Guiding Treatment of Intermediate-Risk Prostate Cancers to Dose-Escalated Image Guided Radiation Therapy Without Hormone Therapy" @default.
• W2889201576 cites W1515738516 @default.
• W2889201576 cites W1549619413 @default.
• W2889201576 cites W1968075176 @default.
• W2889201576 cites W1972298018 @default.
• W2889201576 cites W1977885866 @default.
• W2889201576 cites W1999687329 @default.
• W2889201576 cites W2009101549 @default.
• W2889201576 cites W2088592436 @default.
• W2889201576 cites W2108864389 @default.
• W2889201576 cites W2123664981 @default.
• W2889201576 cites W2146599397 @default.
• W2889201576 cites W2148497849 @default.
• W2889201576 cites W2263511745 @default.
• W2889201576 cites W2296809578 @default.
• W2889201576 cites W2523396458 @default.
• W2889201576 cites W2530874255 @default.
• W2889201576 cites W2582799849 @default.
• W2889201576 cites W2598716793 @default.
• W2889201576 cites W2601335591 @default.
• W2889201576 cites W2608236935 @default.
• W2889201576 cites W2613476616 @default.
• W2889201576 cites W2761180418 @default.
• W2889201576 cites W2769578203 @default.
• W2889201576 cites W2791655860 @default.
• W2889201576 cites W2801312275 @default.
• W2889201576 doi "https://doi.org/10.1016/j.ijrobp.2018.08.030" @default.
• W2889201576 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30170099" @default.
• W2889201576 hasPublicationYear "2019" @default.
• W2889201576 type Work @default.
• W2889201576 sameAs 2889201576 @default.
• W2889201576 citedByCount "33" @default.
• W2889201576 countsByYear W28892015762019 @default.
• W2889201576 countsByYear W28892015762020 @default.
• W2889201576 countsByYear W28892015762021 @default.
• W2889201576 countsByYear W28892015762022 @default.
• W2889201576 countsByYear W28892015762023 @default.
• W2889201576 crossrefType "journal-article" @default.
• W2889201576 hasAuthorship W2889201576A5006261789 @default.
• W2889201576 hasAuthorship W2889201576A5007657275 @default.
• W2889201576 hasAuthorship W2889201576A5009885568 @default.
• W2889201576 hasAuthorship W2889201576A5014582211 @default.
• W2889201576 hasAuthorship W2889201576A5017800332 @default.
• W2889201576 hasAuthorship W2889201576A5020744487 @default.
• W2889201576 hasAuthorship W2889201576A5031467567 @default.
• W2889201576 hasAuthorship W2889201576A5050503254 @default.
• W2889201576 hasAuthorship W2889201576A5053710126 @default.
• W2889201576 hasAuthorship W2889201576A5059043243 @default.
• W2889201576 hasAuthorship W2889201576A5063690225 @default.
• W2889201576 hasAuthorship W2889201576A5069008365 @default.
• W2889201576 hasAuthorship W2889201576A5078925966 @default.
• W2889201576 hasAuthorship W2889201576A5081861396 @default.
• W2889201576 hasAuthorship W2889201576A5082084084 @default.
• W2889201576 hasAuthorship W2889201576A5086730784 @default.
• W2889201576 hasBestOaLocation W28892015761 @default.
• W2889201576 hasConcept C121608353 @default.
• W2889201576 hasConcept C126322002 @default.
• W2889201576 hasConcept C143998085 @default.
• W2889201576 hasConcept C207103383 @default.
• W2889201576 hasConcept C2777899217 @default.
• W2889201576 hasConcept C2780192828 @default.
• W2889201576 hasConcept C44249647 @default.
• W2889201576 hasConcept C509974204 @default.
• W2889201576 hasConcept C71924100 @default.
• W2889201576 hasConcept C72563966 @default.
• W2889201576 hasConcept C90924648 @default.
• W2889201576 hasConceptScore W2889201576C121608353 @default.
• W2889201576 hasConceptScore W2889201576C126322002 @default.
• W2889201576 hasConceptScore W2889201576C143998085 @default.
• W2889201576 hasConceptScore W2889201576C207103383 @default.
• W2889201576 hasConceptScore W2889201576C2777899217 @default.
• W2889201576 hasConceptScore W2889201576C2780192828 @default.
• W2889201576 hasConceptScore W2889201576C44249647 @default.
• W2889201576 hasConceptScore W2889201576C509974204 @default.
• W2889201576 hasConceptScore W2889201576C71924100 @default.
• W2889201576 hasConceptScore W2889201576C72563966 @default.
• W2889201576 hasConceptScore W2889201576C90924648 @default.
• W2889201576 hasFunder F4320319921 @default.

• next